Skip to search boxSkip to navigationSkip to main content

Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene

  • William W. Au(corresponding author)
    ,
  • Salama Abdou-Salama
    ,
  • Ayman Al-Hendy
*Corresponding author for this work
  • University of Texas Medical Branch at Galveston
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Objective.: Estrogen stimulates human papilloma virus oncogene expression, promotes cervical cancer (CC) cell proliferation and prevents apoptosis. Therefore, blockage of estrogen function may have therapeutic application to CC. Methods.: CasKi CC cells were transfected with an adenovirus expressing a dominant negative estrogen receptor gene (Ad-ER-DN) and their responses were investigated by RT-PCR, Flow Cytometry and Western blot assays. Result.: Transfected cells showed disturbance of cell colony morphology, reduced HPV E6 and E7 mRNA, interruption of cell proliferation, reduced cyclin D1 protein and expression of apoptosis. Conclusion.: We report, for the first time, the use of Ad-ER-DN to block estrogen receptors which led to dramatic changes in CC cells that are consistent with the possible reactivation of cellular p53 and Rb function. Their reactivation most likely allowed the recognition of existing chromosome abnormalities as a serious stress signal and the initiation of a cascade of cellular events in response to the stress, including the activation of the core apoptotic machinery which led to self-destruction of the CC cells.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 276-280 (5 pages)

Journal (Volume, Issue Number)

Gynecologic Oncology (Volume 104, Issue 2)

Publication milestones

  • Published - 02/2007

Publication status

Published - 02/2007

ISSN

0090-8258

Publication IDs

  • Scopus: 33846377598
  • PubMed: 17137618

Publication metrics

Metrics

Scopus
citations
SciVal
citations
23
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
1.01
SciVal
Author count
3
SciVal
Paper percentile
76

PlumX, opens in new tab

Citation count
25
Captures
25

Funding Details

The study is partially supported by grants from the John Sealy Memorial Foundation to W.W. Au, NIEHS pilot project grant #ES06676 to S.A.S. and NICHD grant R01-HD 46228 to A.A.
FundersFunding numbers
John Sealy Memorial Foundation
-
NIEHS
06676
NICHD
R01HD046228